Creon (Page 5 of 6)
17 PATIENT COUNSELING INFORMATION
See FDA-approved patient labeling (Medication Guide).
17.1 Dosing and Administration
- Instruct patients and caregivers that CREON should only be taken as directed by their healthcare professional. Patients should be advised that the total daily dose should not exceed 10,000 lipase units/kg body weight/day unless clinically indicated. This needs to be especially emphasized for patients eating multiple snacks and meals per day. Patients should be informed that if a dose is missed, the next dose should be taken with the next meal or snack as directed. Doses should not be doubled [see Dosage and Administration ( 2)].
- Instruct patients and caregivers that CREON should always be taken with food. Patients should be advised that CREON delayed-release capsules and the capsule contents must not be crushed or chewed as doing so could cause early release of enzymes and/or loss of enzymatic activity. Patients should swallow the intact capsules with adequate amounts of liquid at mealtimes. If necessary, the capsule contents can also be sprinkled on soft acidic foods [see Dosage and Administration ( 2)].
17.2 Fibrosing Colonopathy
Advise patients and caregivers to follow dosing instructions carefully, as doses of pancreatic enzyme products exceeding 6,000 lipase units/kg of body weight per meal have been associated with colonic strictures in children below the age of 12 years [see Dosage and Administration ( 2)].
17.3 Allergic Reactions
Advise patients and caregivers to contact their healthcare professional immediately if allergic reactions to CREON develop [see Warnings and Precautions ( 5.5)].
© 2009-2022 AbbVie. All rights reserved.
CREON® is a registered trademark of AbbVie Products LLC.
AbbVie Inc.
North Chicago, IL 60064, U.S.A.
US License Number 1889
20072271 June, 2022
MEDICATION GUIDE CREON® (krē ′ŏn) (pancrelipase) d elayed- r elease c apsules , for oral use |
Read this Medication Guide before you start taking CREON and each time you get a refill. There may be new information. This information does not take the place of talking to your doctor about your medical condition or treatment. |
What is the most important information I should know about CREON? CREON may increase your chance of having a rare bowel disorder called fibrosing colonopathy. This condition is serious and may require surgery. The risk of having this condition may be reduced by following the dosing instructions that your doctor gave you. Call your doctor right away if you have any unusual or severe:
|
What is CREON? CREON is a prescription medicine used to treat people who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis, swelling of the pancreas that lasts a long time (chronic pancreatitis), removal of some or all of the pancreas (pancreatectomy), or other conditions. CREON may help your body use fats, proteins, and sugars from food. CREON contains a mixture of digestive enzymes including lipases, proteases, and amylases from pig pancreas. What should I tell my doctor before taking CREON? Before taking CREON, tell your doctor about all your medical conditions, including if you:
|
How should I take CREON?
|
What are the possible side effects of CREON? CREON may cause serious side effects, including:
|
How should I store CREON?
|
General information about CREON Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use CREON for a condition for which it was not prescribed. Do not give CREON to other people to take, even if they have the same symptoms you have. It may harm them. This Medication Guide summarizes the most important information about CREON. If you would like more information, talk to your doctor. You can ask your doctor or pharmacist for information about CREON that is written for healthcare professionals. For more information, go to www.creon-us.com or call toll-free [1-800-633-9110]. |
What are the ingredients in CREON? Active Ingredient: lipase, protease, amylase Inactive Ingredients: cetyl alcohol, dimethicone, hypromellose phthalate, polyethylene glycol, and triethyl citrate. The shells of the CREON 6,000 USP units of lipase, 12,000 USP units of lipase, and 24,000 USP units of lipase strengths contain: gelatin, red iron oxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide. In addition: The shells for the CREON 3,000 USP units of lipase strength capsules contain titanium dioxide and hypromellose. The shells of the CREON 6,000 USP units of lipase strength capsules contain FD&C Blue No. 2. The shells of the CREON 12,000 USP units of lipase strength capsules contain black iron oxide. The shells of the CREON 36,000 USP units of lipase strength capsules contain gelatin, titanium dioxide, sodium lauryl sulfate and FD&C Blue No. 2. This Medication Guide has been approved by the U.S. Food and Drug Administration. AbbVie Inc. North Chicago, IL 60064, U.S.A. US License Number 1889© 2009-2022 AbbVie Inc. Revised: June, 202220072271 |
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.